Some question disease management’s cost-effectiveness, but major insurers have seen enough to induce them to expand programs
The most attractive element of the congressional reform plan — at least in the eyes of insurers — is drawing fire in at least 30 states
Many states, helped by a few health plans, are striving to develop health information exchanges, encouraged by federal stimulus funds
They’re endangered by a brutal combination of factors, a report last August declared, but things may not be so bad as they looked then
Findings of this retrospective database study further emphasize the importance of effectively managing the side effects of opioid pain therapy and achieving optimum clinical and economic outcomes, thus improving the quality of care
Shrividya Iyer, PhD
Keith L. Davis, MA
Sean Candrilli, PhD
Studies suggest that the benefits of the medications for mild-to-moderate patients are minimal or nonexistent
The Formulary Files
Will insurers provide coverage for a new device that takes much of the guesswork out of screening for this deadly skin cancer?
Thomas Morrow, MD
Disease management should be a function of primary care, some industry proponents argue. Did someone say patient-centered medical home?
Managed Care Outlook